4//SEC Filing
WHITMORE R JANET 4
Accession 0001193125-25-315434
CIK 0000883107other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 11:50 AM ET
Size
19.8 KB
Accession
0001193125-25-315434
Insider Transaction Report
Form 4
SOLESENCE, INC.SLSN
WHITMORE R JANET
Director
Transactions
- Purchase
Common Stock
2025-11-14$1.73/sh+19,789$34,235→ 2,068,931 total - Purchase
Common Stock
2025-11-17$1.87/sh+5,000$9,350→ 2,073,931 total - Purchase
Common Stock
2025-11-18$1.83/sh+267$489→ 2,074,198 total - Purchase
Common Stock
2025-11-19$1.95/sh+5,000$9,750→ 2,079,198 total
Holdings
- 2,049,142
Common Stock
- 20,030
Deferred Common Stock
→ Common Stock (20,030 underlying) - 2,000
Common Stock (right to purchase)
Exercise: $1.85From: 2016-11-17Exp: 2026-11-17→ Common Stock (2,000 underlying) - 20,000
Common Stock (right to purchase)
Exercise: $4.17From: 2022-12-28Exp: 2028-12-28→ Common Stock (20,000 underlying) - 13,334
Common Stock (right to purchase)
Exercise: $1.17From: 2023-12-20Exp: 2029-12-20→ Common Stock (13,334 underlying) - 12,600
Common Stock (right to purchase)
Exercise: $0.61From: 2024-12-27Exp: 2030-12-27→ Common Stock (12,600 underlying) - 12,000
Common Stock (Right to Buy)
Exercise: $2.44From: 2025-12-31Exp: 2031-12-31→ Common Stock (12,000 underlying)
Footnotes (5)
- [F1]Each share of deferred common stock represents the right to receive one share of common stock.
- [F2]The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.
- [F3]Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 20,030 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensaion Plan.
- [F4]The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. These 2000 shares were issued with an exercise price of $1.85.
- [F5]Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.
Documents
Issuer
SOLESENCE, INC.
CIK 0000883107
Entity typeother
Related Parties
1- filerCIK 0001173970
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 11:50 AM ET
- Size
- 19.8 KB